Human prostatic carcinoma cells produce an increase in the synthesis of interleukin‐6 by human osteoblasts

Abstract

Prostate carcinoma cells (PC-3) produce a factor or factors that enhance the synthesis and release of IL-6, a known activator of bone resorption.